SCRC News Alert Scripsamerica Inc (SCRC) 0.1895 02/15/2015 1
Post# of 64074
Posted On: 02/15/2015 12:56:49 PM
Scripsamerica Inc (SCRC) 0.1895 $SCRC
ScripsAmerica CEO Bob Schneiderman Featured on "Executive Leaders Radio"
Business Wire - Thu Feb 12, 7:00AM CST
ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that Bob Schneiderman, Chief Executive Officer and Founding Partner, made a featured appearance on "Executive Leaders Radio", the #1 business weekly radio show in the Mid-Atlantic States broadcast nationally on 91 terrestrial and internet radio stations.
ScripsAmerica's Distributor, PIMD International, Reports Record-High Monthly Revenue in January of over $135,000
GlobeNewswire - Wed Feb 11, 9:55AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company's owned distributor, PIMD International, LLC, ("PIMD"
, reported revenue of $137,031 during the month of January 2015. This represents PIMD's highest monthly revenue in the company's history.
ScripsAmerica's Specialty Pharmacy Announces Over $3.4 Million in Approved Orders in January
GlobeNewswire - Tue Feb 03, 7:00AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $3,488,099 in approved orders during the month of January 2015.
ScripsAmerica Featured in SeeThruEquity's Monthly Newsletter
GlobeNewswire - Thu Jan 22, 7:10AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company is featured in the January 2015 monthly newsletter published by SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies.
Focusing on Underserved Opportunities: ScripsAmerica Analyst Report by Caprock Research and Issued by Small Cap IR
PR Newswire - Thu Jan 15, 6:00AM CST
Analyst Report Issued by Small Cap IR. ScripsAmerica, Inc. (OTCBB: SCRC) - According to a recent report by Research and Markets, the global pharmaceuticals wholesale and distribution market is expected to grow at a compound annual growth rate of 6.82% over the period 2014-2019. According to this report, one of the major drivers of demand for various drugs and medicines, as well as basic healthcare services, are growing populations, increased consumer purchasing power, and rising health awareness. According to Drug Channels Institute, in the United States alone, wholesale drugs are a $300 billion industry.
ScripsAmerica Launches Diabetes Patient Supply Program through Main Avenue Pharmacy
ACCESSWIRE - Mon Jan 12, 10:27AM CST
TYSONS CORNER, VA / ACCESSWIRE / January 12, 2015 / ScripsAmerica, Inc. (OTCQB: SCRC) today announced that the Company has launched a diabetes patient supply program through its wholly-owned subsidiary, Main Avenue Pharmacy.
ScripsAmerica's Main Avenue Pharmacy Records $5.2 Million in Approved Orders for December 2014
ACCESSWIRE - Mon Jan 05, 7:00AM CST
Untitled Document
ScripsAmerica Pays Off $325,000 in High Interest Debt
Marketwired - Tue Dec 30, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has paid off $325,000 in high interest, short-term debt using proceeds from its recent funding by Triumph Healthcare. The Company paid the full balance of two one-year term loans in the amounts of $250,000 and $75,000, each with an interest rate of 24% per annum.
ScripsAmerica Secures $4 Million Line of Credit From Triumph Healthcare Finance
Marketwired - Wed Dec 10, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off its current high interest debt.
ScripsAmerica's Specialty Pharmacy Records Over $5 Million in Approved Orders for the Third Consecutive Month
Marketwired - Wed Dec 03, 7:03AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,257,753 in approved orders during November of 2014. This represents the third consecutive month that ScripsAmerica's specialty pharmacy generated over $5 million in sales.
WSA Speaks to Three Companies on the Rise
Marketwired - Tue Dec 02, 10:27AM CST
ClearOne (NASDAQ: CLRO) CEO Zee Hakimoglu discussed the company's favorable Q3 results reporting 27% revenue growth from last year with solid profitability. She outlined ClearOne's products and patents and talked about two recent acquisitions and how these acquisitions have positioned ClearOne favorably in their traditional audio conferencing market as well as in the emerging media collaboration market.
CLRO: 10.39 (+0.24)
SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20
ACCESSWIRE - Tue Dec 02, 8:01AM CST
New York, NY / ACCESSWIRE / December 2, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on ScripsAmerica, Inc. (OTCQB: SCRC) with a 12-month price target of $1.20.
ScripsAmerica Exercises Option to Acquire 90% of PIMD International, LLC
Marketwired - Mon Dec 01, 7:01AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that it has exercised an option to acquire 90% of PIMD International, LLC, ("PIMD" , a Florida-based pharmaceutical wholesaler that the Company has had a working relationship with since the fourth quarter of 2013.
ScripsAmerica Highlights CEO Interviews From Recent Investor Conference
Marketwired - Tue Nov 25, 7:00AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that its CEO, Bob Schneiderman, recently conducted interviews with financial outlets 'Stock News Now' (SNN) and 'New to the Street' (NTTS) at the SeeThru Equity Conference in NY.
ScripsAmerica Comments on Financial Results for the Third Quarter of 2014
Marketwired - Wed Nov 19, 3:51PM CST
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the third quarter ended September 30, 2014.
ScripsAmerica Announces Full Acquisition of Main Avenue Pharmacy
Marketwired - Wed Nov 19, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has recently acquired 100% of Main Avenue Pharmacy, Inc. ("MAVP" , a New Jersey-based pharmacy that specializes in prescription topical creams.
ScripsAmerica Announces Conference Call to Provide Business Update and Discuss Third Quarter Fiscal 2014 Results
Business Wire - Mon Nov 17, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that it will host a conference call at 10 a.m. Eastern Time, Wednesday, December 3, 2014 to comment on current business conditions and market drivers and to discuss various initiatives of the Company. Robert Schneiderman, Chief Executive Officer, Founding Partner and Jeffrey Andrews, Chief Financial Officer will also discuss the Company's recent 10-Q filing for the third quarter ended September 30, 2014 and conduct a question and answer session.
ScripsAmerica CEO Bob Schneiderman Featured on "Executive Leaders Radio"
Business Wire - Thu Feb 12, 7:00AM CST
ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that Bob Schneiderman, Chief Executive Officer and Founding Partner, made a featured appearance on "Executive Leaders Radio", the #1 business weekly radio show in the Mid-Atlantic States broadcast nationally on 91 terrestrial and internet radio stations.
ScripsAmerica's Distributor, PIMD International, Reports Record-High Monthly Revenue in January of over $135,000
GlobeNewswire - Wed Feb 11, 9:55AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company's owned distributor, PIMD International, LLC, ("PIMD"
, reported revenue of $137,031 during the month of January 2015. This represents PIMD's highest monthly revenue in the company's history. ScripsAmerica's Specialty Pharmacy Announces Over $3.4 Million in Approved Orders in January
GlobeNewswire - Tue Feb 03, 7:00AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $3,488,099 in approved orders during the month of January 2015.
ScripsAmerica Featured in SeeThruEquity's Monthly Newsletter
GlobeNewswire - Thu Jan 22, 7:10AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company is featured in the January 2015 monthly newsletter published by SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies.
Focusing on Underserved Opportunities: ScripsAmerica Analyst Report by Caprock Research and Issued by Small Cap IR
PR Newswire - Thu Jan 15, 6:00AM CST
Analyst Report Issued by Small Cap IR. ScripsAmerica, Inc. (OTCBB: SCRC) - According to a recent report by Research and Markets, the global pharmaceuticals wholesale and distribution market is expected to grow at a compound annual growth rate of 6.82% over the period 2014-2019. According to this report, one of the major drivers of demand for various drugs and medicines, as well as basic healthcare services, are growing populations, increased consumer purchasing power, and rising health awareness. According to Drug Channels Institute, in the United States alone, wholesale drugs are a $300 billion industry.
ScripsAmerica Launches Diabetes Patient Supply Program through Main Avenue Pharmacy
ACCESSWIRE - Mon Jan 12, 10:27AM CST
TYSONS CORNER, VA / ACCESSWIRE / January 12, 2015 / ScripsAmerica, Inc. (OTCQB: SCRC) today announced that the Company has launched a diabetes patient supply program through its wholly-owned subsidiary, Main Avenue Pharmacy.
ScripsAmerica's Main Avenue Pharmacy Records $5.2 Million in Approved Orders for December 2014
ACCESSWIRE - Mon Jan 05, 7:00AM CST
Untitled Document
ScripsAmerica Pays Off $325,000 in High Interest Debt
Marketwired - Tue Dec 30, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has paid off $325,000 in high interest, short-term debt using proceeds from its recent funding by Triumph Healthcare. The Company paid the full balance of two one-year term loans in the amounts of $250,000 and $75,000, each with an interest rate of 24% per annum.
ScripsAmerica Secures $4 Million Line of Credit From Triumph Healthcare Finance
Marketwired - Wed Dec 10, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off its current high interest debt.
ScripsAmerica's Specialty Pharmacy Records Over $5 Million in Approved Orders for the Third Consecutive Month
Marketwired - Wed Dec 03, 7:03AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,257,753 in approved orders during November of 2014. This represents the third consecutive month that ScripsAmerica's specialty pharmacy generated over $5 million in sales.
WSA Speaks to Three Companies on the Rise
Marketwired - Tue Dec 02, 10:27AM CST
ClearOne (NASDAQ: CLRO) CEO Zee Hakimoglu discussed the company's favorable Q3 results reporting 27% revenue growth from last year with solid profitability. She outlined ClearOne's products and patents and talked about two recent acquisitions and how these acquisitions have positioned ClearOne favorably in their traditional audio conferencing market as well as in the emerging media collaboration market.
CLRO: 10.39 (+0.24)
SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20
ACCESSWIRE - Tue Dec 02, 8:01AM CST
New York, NY / ACCESSWIRE / December 2, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on ScripsAmerica, Inc. (OTCQB: SCRC) with a 12-month price target of $1.20.
ScripsAmerica Exercises Option to Acquire 90% of PIMD International, LLC
Marketwired - Mon Dec 01, 7:01AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that it has exercised an option to acquire 90% of PIMD International, LLC, ("PIMD"
, a Florida-based pharmaceutical wholesaler that the Company has had a working relationship with since the fourth quarter of 2013. ScripsAmerica Highlights CEO Interviews From Recent Investor Conference
Marketwired - Tue Nov 25, 7:00AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that its CEO, Bob Schneiderman, recently conducted interviews with financial outlets 'Stock News Now' (SNN) and 'New to the Street' (NTTS) at the SeeThru Equity Conference in NY.
ScripsAmerica Comments on Financial Results for the Third Quarter of 2014
Marketwired - Wed Nov 19, 3:51PM CST
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the third quarter ended September 30, 2014.
ScripsAmerica Announces Full Acquisition of Main Avenue Pharmacy
Marketwired - Wed Nov 19, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has recently acquired 100% of Main Avenue Pharmacy, Inc. ("MAVP"
, a New Jersey-based pharmacy that specializes in prescription topical creams. ScripsAmerica Announces Conference Call to Provide Business Update and Discuss Third Quarter Fiscal 2014 Results
Business Wire - Mon Nov 17, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that it will host a conference call at 10 a.m. Eastern Time, Wednesday, December 3, 2014 to comment on current business conditions and market drivers and to discuss various initiatives of the Company. Robert Schneiderman, Chief Executive Officer, Founding Partner and Jeffrey Andrews, Chief Financial Officer will also discuss the Company's recent 10-Q filing for the third quarter ended September 30, 2014 and conduct a question and answer session.
(0)
(0)Scroll down for more posts ▼